J&J taps AlivaMab for multi-target antibody discovery effort

Johnson & Johnson has tasked AlivaMab Discovery Services with finding antibody-drug candidates against multiple targets. The project is built on the AlivaMab Mouse platform that is already used by in-house R&D teams at large biopharma companies.